Evidence map›Paper›PMID 33800991›Full record

ReviewJournal of clinical medicine2021

Rare Forms of Lipomatosis: Dercum's Disease and Roch-Leri Mesosomatous Lipomatosis.

Madleen Lemaitre, Sebastien Aubert, Benjamin Chevalier, Arnaud Jannin, Julien Bourry, Gaetan Prévost, Herve Lefebvre, Marie-Christine Vantyghem

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Madleen LemaitreEndocrinology, Diabetology and Metabolism, CHU Lille, 59000 Lille, France.ORCID 0000-0002-3203-717X
Sebastien AubertDepartment of Biopathology, CHU Lille, 59000 Lille, France.
Benjamin ChevalierEndocrinology, Diabetology and Metabolism, CHU Lille, 59000 Lille, France.
Arnaud JanninEndocrinology, Diabetology and Metabolism, CHU Lille, 59000 Lille, France.
Julien BourryEndocrinology, Diabetology and Metabolism, CHU Lille, 59000 Lille, France.
Gaetan PrévostDepartment of Endocrinology, Diabetes and Metabolic Diseases, Rouen University Hospital, 76000 Rouen, France.
Herve LefebvreDepartment of Endocrinology, Diabetes and Metabolic Diseases, Rouen University Hospital, 76000 Rouen, France.
Marie-Christine VantyghemEndocrinology, Diabetology and Metabolism, CHU Lille, 59000 Lille, France.
Centre Hospitalier Universitaire de Lille · FRUniversité de Rouen Normandie · FRInserm · FRUniversité de Lille · FR

Funding

PHRC 2009; Clinical Trial Registration; NCT0178428
6 · The paper itself

Abstract

In contrast to obesity, which is very frequent, lipomatosis and lipodystrophy syndromes are rare diseases of adipose tissue. Lipodystrophy syndromes are characterized by metabolic abnormalities associated with partial or generalized lipoatrophy. Lipomatosis is defined by the presence of several body lipomas without lipoatrophy. Dercum's disease (DD) and Roch-Leri mesosomatous lipomatosis (RLML) are rare and poorly characterized forms of lipomatosis. They have raised little clinical interest despite the non-negligible consequences of DD on quality of life. The main clinical presentation of these diseases includes multiple lipomas, which are painful in DD (in contrast to RLML). The two diseases are frequently associated with obesity and metabolic syndrome, with hypertension, diabetes, or dyslipidemia. The long-term course of the diseases remains poorly described. DD affects mainly women, whereas RLML mostly affects men. In both diseases lipomas are found on the back and thighs, as well as on the abdomen in DD and the forearms in RLML. The painful lipomas tend to recur after surgery in DD (in contrast to RLML). Most cases are sporadic. No specific treatment has been identified, as the pathophysiology remains unknown. Nevertheless, low-grade fat inflammation and specific abnormalities such as hyperbasophilia deserve further investigation. The aim of this review is to analyze the available literature on the topic.

Indexed as

adipose tissueDercum’s diseaselipodystrophylipomatosisRoch-Leri mesosomatous lipomatosis

Identifiers

PMID33800991
PMCPMC8003963
OpenAlexW3138329280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.